165 related articles for article (PubMed ID: 32042753)
1. DNA methylation-based prognostic biomarkers of acute myeloid leukemia patients.
Hu L; Gao Y; Shi Z; Liu Y; Zhao J; Xiao Z; Lou J; Xu Q; Tong X
Ann Transl Med; 2019 Dec; 7(23):737. PubMed ID: 32042753
[TBL] [Abstract][Full Text] [Related]
2. Developing DNA methylation-based prognostic biomarkers of acute myeloid leukemia.
Gao C; Zhuang J; Zhou C; Liu L; Liu C; Li H; Zhao M; Liu G; Sun C
J Cell Biochem; 2018 Dec; 119(12):10041-10050. PubMed ID: 30171717
[TBL] [Abstract][Full Text] [Related]
3. Enhanced MCM5 Level Predicts Bad Prognosis in Acute Myeloid Leukemia.
Wang S; Wu W; Han X
Mol Biotechnol; 2023 Aug; 65(8):1242-1252. PubMed ID: 36479666
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of ferroptosis-related genes and their methylation in AML.
Zhou F; Chen B
Hematology; 2021 Dec; 26(1):919-930. PubMed ID: 34789073
[TBL] [Abstract][Full Text] [Related]
5. Identification of the key genes and microRNAs in adult acute myeloid leukemia with FLT3 mutation by bioinformatics analysis.
Chen S; Chen Y; Zhu Z; Tan H; Lu J; Qin P; Xu L
Int J Med Sci; 2020; 17(9):1269-1280. PubMed ID: 32547322
[No Abstract] [Full Text] [Related]
6. Identification of latent biomarkers in connection with progression and prognosis in oral cancer by comprehensive bioinformatics analysis.
Reyimu A; Chen Y; Song X; Zhou W; Dai J; Jiang F
World J Surg Oncol; 2021 Aug; 19(1):240. PubMed ID: 34384424
[TBL] [Abstract][Full Text] [Related]
7. Identification and analysis of methylation signature genes and association with immune infiltration in pediatric acute myeloid leukemia.
Zhu H; Xu Y; Xia J; Guo X; Fang Y; Fan J; Li F; Wu J; Zheng G; Liu Y
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14965-14982. PubMed ID: 37606761
[TBL] [Abstract][Full Text] [Related]
8. Low expression of the metabolism-related gene SLC25A21 predicts unfavourable prognosis in patients with acute myeloid leukaemia.
Wang W; Liang Q; Zhao J; Pan H; Gao Z; Fang L; Zhou Y; Shi J
Front Genet; 2022; 13():970316. PubMed ID: 36246603
[TBL] [Abstract][Full Text] [Related]
9. A novel scoring system for acute myeloid leukemia risk assessment based on the expression levels of six genes.
Zhao X; Li Y; Wu H
Int J Mol Med; 2018 Sep; 42(3):1495-1507. PubMed ID: 29956722
[TBL] [Abstract][Full Text] [Related]
10. Systematic Construction and Validation of an RNA-Binding Protein-Associated Prognostic Model for Acute Myeloid Leukemia.
Luo H; Zhang Y; Hu N; He Y; He C
Front Genet; 2021; 12():715840. PubMed ID: 34630514
[No Abstract] [Full Text] [Related]
11. The Multi-Omic Prognostic Model of Oxidative Stress-Related Genes in Acute Myeloid Leukemia.
Dong C; Zhang N; Zhang L
Front Genet; 2021; 12():722064. PubMed ID: 34659343
[No Abstract] [Full Text] [Related]
12. Identification of Methylation Markers and Differentially Expressed Genes with Prognostic Value in Breast Cancer.
Wu J; Zhang Y; Li M
J Comput Biol; 2019 Dec; 26(12):1394-1408. PubMed ID: 31290690
[TBL] [Abstract][Full Text] [Related]
13. SPINK2 is a prognostic biomarker related to immune infiltration in acute myeloid leukemia.
Chen X; Zhao L; Yu T; Zeng J; Chen M
Am J Transl Res; 2022; 14(1):197-210. PubMed ID: 35173838
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of inferior prognostic genes associated with immune signatures and chemotherapy outcome in acute myeloid leukemia.
Wang J; Hao JP; Uddin MN; Wu Y; Chen R; Li DF; Xiong DQ; Ding N; Yang JH; Ding XS
Aging (Albany NY); 2021 Jun; 13(12):16445-16470. PubMed ID: 34148032
[TBL] [Abstract][Full Text] [Related]
15. Identification of key DNA methylation-driven genes in prostate adenocarcinoma: an integrative analysis of TCGA methylation data.
Xu N; Wu YP; Ke ZB; Liang YC; Cai H; Su WT; Tao X; Chen SH; Zheng QS; Wei Y; Xue XY
J Transl Med; 2019 Sep; 17(1):311. PubMed ID: 31533842
[TBL] [Abstract][Full Text] [Related]
16. The signature based on seven genomic instability-related genes could predict the prognosis of acute myeloid leukemia patients.
Nie L; Zhang Y; You Y; Lin C; Li Q; Deng W; Ma J; Luo W; He H
Hematology; 2022 Dec; 27(1):840-848. PubMed ID: 35924822
[TBL] [Abstract][Full Text] [Related]
17. A Novel Scoring System for Risk Assessment of Elderly Patients With Cytogenetically Normal Acute Myeloid Leukemia Based on Expression of Three AQP1 DNA Methylation-Associated Genes.
Yin X; Huang H; Huang S; Xu A; Fan F; Luo S; Yan H; Chen L; Sun C; Hu Y
Front Oncol; 2020; 10():566. PubMed ID: 32373535
[No Abstract] [Full Text] [Related]
18. TBC1D16 predicts chemosensitivity and prognosis in adult acute myeloid leukemia (AML) patients.
Liu H; Chen P; Yang YL; Zhu KW; Wang T; Tang L; Liu YL; Cao S; Zhou G; Zeng H; Zhao XL; Zhang W; Chen XP
Eur J Pharmacol; 2021 Mar; 895():173894. PubMed ID: 33476656
[TBL] [Abstract][Full Text] [Related]
19. Identification and Validation of a Prognostic Risk-Scoring Model Based on Ferroptosis-Associated Cluster in Acute Myeloid Leukemia.
Wang J; Zhuo Z; Wang Y; Yang S; Chen J; Wang Y; Geng S; Li M; Du X; Lai P; Weng J
Front Cell Dev Biol; 2021; 9():800267. PubMed ID: 35127715
[No Abstract] [Full Text] [Related]
20. High Expression of ACOT2 Predicts Worse Overall Survival and Abnormal Lipid Metabolism: A Potential Target for Acute Myeloid Leukemia.
Yin X; Lyu C; Li Z; Wang Q; Ding Y; Wang Y; Qiu Y; Cui S; Guo D; Xu R
J Healthc Eng; 2022; 2022():2669114. PubMed ID: 36193167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
